Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPLP.L Regulatory News (PLP)

  • There is currently no data for PLP

Director/PDMR Shareholding

22 Sep 2020 15:59

RNS Number : 7716Z
Polypipe Group PLC
22 September 2020
 

Polypipe Group plc (the "Company")

Notification of transactions by Person Discharging Managerial Responsibilities

The Company announces that on 16 September 2020, Paul James, Chief Financial Officer and a Person Discharging Managerial Responsibilities, exercised a nil-cost option over 30,755 ordinary shares of £0.001 each in the capital of the Company ('Shares') in accordance with the Deferred Share Award that was granted to him on 21 March 2018.

Full details of the Award were included in a regulatory announcement released on 21 March 2018 and in the Company's 2017 Annual Report and Accounts. The Company's Employee Benefit Trust has today transferred 16,300 Shares to Mr James which represents the net number of Shares due to him after the appropriate tax and national insurance liabilities were taken into account.

The notification below, which have been made in accordance with the requirements of the EU Market Abuse Regulation, provide further detail.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Paul James

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Financial Officer/Director and PDMR

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Polypipe Group plc

b)

 

LEI

 

 

2138005IF1N2RKJ6KO18

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary Shares ("Shares") of £0.001 each in the capital of Polypipe Group plc

 

 

GB00BKRC5K31

 

b)

 

Nature of the transaction

 

 

Acquisition of Shares for no consideration pursuant to the exercise of nil-cost options comprised in the Deferred Share Award ("DSA") granted on 21 March 2018

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

Nil

 

16,300 - Number of DSA Shares acquired after reduction for appropriate tax and national insurance liabilities.

 

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

N/A

 

 

 

 

 

e)

 

Date of the transaction

 

 

22 September 2020

f)

 

Place of the transaction

 

 

Outside a trading venue

 

Enquiries:

Emma Versluys, Company Secretary

+44 (0) 1709 770 000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHKKBBPQBKDFCB
Date   Source Headline
17th Aug 201712:29 pmRNSHolding(s) in Company
8th Aug 20175:18 pmRNSDirector/PDMR Shareholding
8th Aug 20177:00 amRNSHalf-year Report
1st Aug 20174:22 pmRNSDirector Declaration
18th Jul 20179:49 amRNSHolding(s) in Company
6th Jul 20174:51 pmRNSHolding(s) in Company
4th Jul 201712:39 pmRNSHolding(s) in Company
3rd Jul 201711:19 amRNSTotal Voting Rights
28th Jun 20173:56 pmRNSHolding(s) in Company
28th Jun 20179:42 amRNSHolding(s) in Company
23rd Jun 20174:58 pmRNSHolding(s) in Company
14th Jun 20171:07 pmRNSHolding(s) in Company
13th Jun 20175:26 pmRNSHolding(s) in Company
7th Jun 20174:04 pmRNSHolding(s) in Company
25th May 201710:04 amRNSHolding(s) in Company
24th May 201711:28 amRNSResult of AGM
24th May 20177:00 amRNSDirectorate Change
24th May 20177:00 amRNSTrading Update
19th May 201711:35 amRNSHolding(s) in Company
3rd May 20179:48 amRNSDirector/PDMR Shareholding
28th Apr 20173:49 pmRNSHolding(s) in Company
26th Apr 201711:26 amRNSDirector/PDMR Shareholding
20th Apr 20177:30 amRNSAnnual Financial Report
30th Mar 20177:00 amRNSFinal Results
15th Feb 201710:40 amRNSHolding(s) in Company
3rd Feb 20174:20 pmRNSHolding(s) in Company
17th Jan 201710:53 amRNSHolding(s) in Company
6th Jan 20175:16 pmRNSHolding(s) in Company
6th Jan 20173:25 pmRNSHolding(s) in Company
2nd Dec 201612:55 pmRNSDirector/PDMR Shareholding
30th Nov 20164:35 pmRNSPrice Monitoring Extension
24th Nov 20164:25 pmRNSHolding(s) in Company
16th Nov 20169:06 amRNSHolding(s) in Company
15th Nov 20167:00 amRNSTrading Update
4th Nov 20165:22 pmRNSHolding(s) in Company
3rd Oct 20165:37 pmRNSTotal Voting Rights
19th Sep 20161:13 pmRNSDirector/PDMR Shareholding
16th Sep 20164:08 pmRNSDirector/PDMR Shareholding
8th Sep 201610:44 amRNSTransaction in Own Shares
6th Sep 20162:44 pmRNSDirector/PDMR Shareholding
6th Sep 20162:43 pmRNSDirector/PDMR Shareholding
1st Sep 201610:04 amRNSTotal Voting Rights
31st Aug 20161:01 pmRNSHolding(s) in Company
30th Aug 20166:01 pmRNSTransaction in Own Shares
26th Aug 20165:18 pmRNSTransaction in Own Shares
26th Aug 201611:26 amRNSHolding(s) in Company
25th Aug 20165:32 pmRNSTransaction in Own Shares
24th Aug 20166:00 pmRNSTransaction in Own Shares
24th Aug 201611:20 amRNSHolding(s) in Company
23rd Aug 20166:30 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.